Sugeac Elena, Fossey Christine, Ladurée Daniel, Schmidt Sylvie, Laumond Geraldine, Aubertin Anne-Marie
Centre d'Etudes et de Recherche sur le Medicament de Normandie, UFR des Sciences Pharmaceutiques, Caen Cedex, France.
J Enzyme Inhib Med Chem. 2004 Dec;19(6):497-509. doi: 10.1080/14756360412331280554.
Selected for their expected ability to inhibit HIV replication, a series of eight heterodimers containing a Nucleoside Reverse Transcriptase Inhibitor (NRTI) and an Integrase Inhibitor (INI), bound by a linker, were designed and synthesized. For the NRTIs, d4U, d2U and d4T were chosen. For the INIs, 4-[1-(4-fluorobenzyl)-1H-pyrrol-2-yl]-2,4-dioxobutyric acid (6) and 4-(3,5-dibenzyloxyphenyl)-2,4-dioxobutyric acid (9) (belonging to the beta-diketo acids class) were chosen. The conjugation of the two different inhibitors (NRTI and INI) was performed using an amino acid (glycine or beta-alanine) as a cleavable linker.
为了筛选出有望抑制HIV复制的化合物,设计并合成了一系列由八个异二聚体组成的化合物,这些异二聚体包含一个核苷逆转录酶抑制剂(NRTI)和一个整合酶抑制剂(INI),两者通过一个连接子相连。对于NRTI,选用了d4U、d2U和d4T。对于INI,选用了4-[1-(4-氟苄基)-1H-吡咯-2-基]-2,4-二氧代丁酸(6)和4-(3,5-二苄氧基苯基)-2,4-二氧代丁酸(9)(属于β-二酮酸类)。使用氨基酸(甘氨酸或β-丙氨酸)作为可裂解连接子来实现两种不同抑制剂(NRTI和INI)的共轭。